- Chronic health conditions: federal strategy needed to coordinate diet-related efforts : report to Congressional Requesters1
- Clinical labs: studies suggest biopsy specimen misidentification and contamination errors are infrequent : report to the Ranking Member, Committee on Finance, U.S. Senate1
- Communication and management challenges impeded HHS's response to the zero-tolerance policy1
- Comparative effectiveness research: Patient-Centered Outcomes Research Institute and HHS continue activities and plan new efforts : report to Congressional committees1
- Concerns persist about opioid overdoses and Medicare beneficiaries’ access to treatment and overdose-reversal drugs1
- Cybersecurity: HHS defined roles and responsibilities, but can further improve collaboration : report to Congressional requesters1
- Cybersecurity: NIH needs to take further actions to resolve control deficiencies and improve its program : report to congressional requesters1
- DOD and VA health care: suicide prevention efforts and recommendations for improvement : testimony before the Subcommittee on National Security, Committee on Oversight and Reform, House of Representatives1
- DOD health care: DOD should monitor implementation of its clinical practice guidelines : report to Congressional committees1
- Data on Medicaid Managed Care payments to providers are incomplete and inaccurate1
- Defense health care: DOD needs to fully assess its nonclinical suicide prevention efforts and address any impediments to effectiveness : report to Congressional committees1
- Defense health care: actions needed to define and sustain wartime medical skills for enlisted personnel : report to Congressional committees1
- Defense health care: additional information and monitoring needed to better position DOD for restructuring medical treatment facilities : report to Congressional committees1
- Defense health care: plans needed to ensure implementation of required elements for TRICARE’s managed care support contracts : report to Congressional committees1
- Despite savings on many lab tests in 2019, total Medicare spending increased slightly because of increased utilization for certain high-priced tests1
- Drug development: Pathway for approving antibacterial and antifungal drugs for patients with limited treatment options is infrequently used : report to congressional committees1
- Drug misuse: sustained national efforts are necessary for prevention, response, and recovery : report to the Congress1
- Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate1
- Electronic health records: DOD has made progress in implementing a new system, but challenges persist : report to Congressional committees1
- Electronic health records: VA has made progress in preparing for new system, but subsequent test findings will need to be addressed : report to Congressional committees1